Analysts See $-0.04 EPS for Theratechnologies Inc. (TH)

March 14, 2018 - By Maria Brooks

 Analysts See $ 0.04 EPS for Theratechnologies Inc. (TH)

Analysts expect Theratechnologies Inc. (TSE:TH) to report $-0.04 EPS on April, 5.They anticipate $0.01 EPS change or 33.33 % from last quarter’s $-0.03 EPS. After having $-0.06 EPS previously, Theratechnologies Inc.’s analysts see -33.33 % EPS growth. The stock increased 0.72% or $0.07 during the last trading session, reaching $9.86. About 313,797 shares traded or 119.45% up from the average. Theratechnologies Inc. (TSE:TH) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Theratechnologies Inc. (TSE:TH) Ratings Coverage

Among 2 analysts covering Theratechnologies Inc. (TSE:TH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Theratechnologies Inc. had 6 analyst reports since February 25, 2016 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, November 11 by National Bank Canada.

Theratechnologies Inc., specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients. The company has market cap of $739.27 million. The Company’s lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. It currently has negative earnings.

More important recent Theratechnologies Inc. (TSE:TH) news were published by: which released: “Theratechnologies Announces Financial Results for Second Quarter of 2017” on July 12, 2017, also published article titled: “Theratechnologies, Taimed get FDA nod, and several firsts, for HIV drug”, published: “Theratechnologies Inc.: Ibalizumab 24-Week Pivotal Phase III Study Results …” on January 18, 2017. More interesting news about Theratechnologies Inc. (TSE:TH) was released by: and their article: “Theratechnologies Has An Unheralded Blockbuster” with publication date: November 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: